Switch Language

News

Please find below the last exciting news from GSV & Life Sciences Sector.

Save the date – Genève sciences de la vie

Mercredi 6 novembre 2019 – 17h00
FER Genève – 98, rue de Saint Jean – 1201 Genève

L’association Genève Sciences de la Vie a le plaisir de vous convier à fêter ses 70 ans
pour une soirée de réflexion sur le passé, le présent et le futur des sciences de la vie.

Avec la participation de:
Pierre Maudet, Conseiller d’État.
Luc Ferry, écrivain et philosophe.
Geneviève Berger, médecin et biophysicienne,
Directrice du département R&D du groupe Firmenich.

Table ronde animée par Benoît Dubuis.

June 14, 2019

AstraZeneca’s U.S. COVID-19 trial is back on track after 45-day hold

More info

October 23, 2020

Ultragenyx dives into Duchenne with $40M Solid Bio deal

More info

October 23, 2020

FDA cleared medium-risk medical devices that failed agency's own protocols: study

More info

October 23, 2020

Alnylam makes case for lumasiran in infants ahead of FDA ruling  

More info

October 23, 2020

Sirnaomics nabs a major $105M funding round for next stage of its RNA work

More info

October 23, 2020

Convalescent plasma fails phase 2 in moderate COVID-19 patients

More info

October 23, 2020

Retrophin buys up Orphan Technologies, spending $90M on rare disease drug

More info

October 23, 2020

Koller's insitro snaps up Haystack to build up machine learning tech

More info

October 23, 2020

KSQ boosts PARP inhibition in animal models of ovarian and breast cancers with USP1 inhibitor

More info

October 23, 2020

Du potentiel sans faim

L’obésité et la malnutrition tuent toujours autant. S’ajoutent à cela l’usage de plastiques polluants, les...

More info

October 22, 2020

Plus de 15 millions pour la biotech Araris

La jeune société zurichoise Araris clôt un premier tour de table. Sa technologie permet une...

More info

October 22, 2020

Origyn veut contrer la contrefaçon horlogère

Lancée à la rentrée par Vincent Perriard, ancien CEO de HYT Watches, Origyn permet d’authentifier...

More info

October 22, 2020

Les obligations convertibles : meilleur refuge du moment

«Si vous êtes absolument certain que le marché montera, achetez des actions. Sinon … fiez-vous...

More info

October 22, 2020

«Nous souhaitons mettre à disposition notre vaccin à un prix raisonnable»

Le nouveau bureau suisse de Moderna est en plein essor, entre développement de ses forces...

More info

October 22, 2020

Roche s’allie à la biotech américaine Atea pour un traitement oral contre le Covid-19

Le groupe pharmaceutique suisse Roche vient d’annoncer un partenariat avec la société biopharmaceutique américaine Atea...

More info

October 22, 2020

Santé: en Suisse, près de 2 jeunes médecins sur 3 sont des femmes

Selon des statistiques de l’OFS datant de 2018, les femmes sont plus nombreuses chez les...

More info

October 22, 2020

Faiblesses de notre système de santé : la smarter medicine affiche ses ambitions

Les primes maladie ne vont que très modérément augmenter cette année. Mais la question des...

More info

October 22, 2020

Azura Ophthalmics bags $20M to tackle root cause of dry eye

More info

October 22, 2020

[Infographics] COVID-19: The Role of Medical Technology

Medical technology plays a vital role in testing who may have contracted COVID-19, ensuring that...

More info

October 22, 2020

New CEO, major Roche biobucks pact: Now, Rheos nabs ex-Biogen R&D exec as CSO

More info

October 22, 2020

Be Biopharma debuts with $52M to advance engineered B-cell therapies

More info

October 22, 2020

Pandemic vaccine programs cannot tell us whether they will save lives: Doshi

More info

October 22, 2020

How a drug derived from antiparasitic might combat blood cancer

More info

October 22, 2020

Quest Diagnostics ups guidance, notches major sales growth and gives back CARES Act cash

More info

October 22, 2020

Fresh from early successes, RA Capital bags $461M for new fund

More info

October 22, 2020

As DeFord retires as CTO, BD plays musical chairs with R&D, life science leaders

More info

October 22, 2020

Roche to pay Atea $350M for ex-U.S. rights to COVID-19 antiviral

More info

October 22, 2020

Pfizer snaps up antibiotics maker Arixa and its oral Avycaz follow-up

More info

October 22, 2020

Could a language test diagnose Alzheimer's? IBM is laying the groundwork

More info

October 22, 2020

Chutes & Ladders—Kite Pharma veteran Nowers takes the helm at ONK

More info

October 22, 2020

Pour agir sur les coûts de la santé, la CSS prône les soins intégrés

Il y a toujours plus de spécialistes à coordonner pour le bien-être du patient. Et...

More info

October 22, 2020

Patient death casts a shadow on AstraZeneca's COVID-19 trial: report

More info

October 21, 2020

Anatomy of a deal: How MyoKardia got BMS to bump up its buyout to $13B

More info

October 21, 2020

Stanford Medicine launches home COVID-19 testing study covering greater San Francisco

More info

October 21, 2020

One pandemic, $2 billion, 3 months: Top COVID-19 player Thermo Fisher posts hefty Q3 revenue

More info

October 21, 2020